Page last updated: 2024-09-03

win 56291 and win 54954

win 56291 has been researched along with win 54954 in 2 studies

Compound Research Comparison

Studies
(win 56291)
Trials
(win 56291)
Recent Studies (post-2010)
(win 56291)
Studies
(win 54954)
Trials
(win 54954)
Recent Studies (post-2010) (win 54954)
5012420

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chapman, MS; Diana, GD; Dutko, FJ; Kim, KH; Mallamo, JP; Minor, I; Oliveira, M; Pevear, DC; Rossmann, MG1
Andries, K; Chapman, MS; Diana, GD; Gong, ZX; Kim, KH; Kremer, MJ; Minor, I; Oliveira, MA; Rossmann, MG; Willingmann, P1

Other Studies

2 other study(ies) available for win 56291 and win 54954

ArticleYear
Conformationally restricted analogues of disoxaril: a comparison of the activity against human rhinovirus types 14 and 1A.
    Journal of medicinal chemistry, 1992, Dec-11, Volume: 35, Issue:25

    Topics: Antiviral Agents; Binding Sites; Humans; Isoxazoles; Models, Molecular; Rhinovirus; Structure-Activity Relationship

1992
A comparison of the anti-rhinoviral drug binding pocket in HRV14 and HRV1A.
    Journal of molecular biology, 1993, Mar-05, Volume: 230, Issue:1

    Topics: Amino Acid Sequence; Antiviral Agents; Binding Sites; Capsid; Conserved Sequence; Drug Design; Isoxazoles; Models, Molecular; Molecular Sequence Data; Pyridazines; Rhinovirus; Sequence Alignment; Serotyping; Structure-Activity Relationship

1993